The Eof ıInsulin Use Education on Safe Drug Administration, Pain Level and Perception of Treatment in Patients With Type 2 Diabetes
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 84
- 试验地点
- 1
- 主要终点
- Fırst follow - up survey
研究概览
简要总结
This study was conducted to evaluate the effect of individual insulin use training given to patients with type 2 diabetes using insulin on safe drug administration, pain level and perception of treatment. The study was conducted between October 2022 and March 2023 with a randomized control group.
详细描述
Objective
The aim of this study was to examine the effects of individual insulin use training given to patients with Type 2 diabetes on safe drug administration, pain level and treatment perception, and to contribute to both national and international literature.
Method: It was conducted between October 2022 and March 2023 as a randomized controlled study in a pre-test-post-test order to determine the effect of individual insulin use education given to patients with type 2 diabetes on safe drug administration, pain level and treatment perception. The data were collected by the researchers with the descriptive information form of the patients, the Insulin Administration Skill Observation Form, the Visual Analogue Scale and the Insulin Therapy Evaluation Scale.
Data Collection: Face-to-face and individual interviews with patients who applied to the Internal Diseases and Endocrinology Polyclinic and Diabetes Nursing Polyclinics of a state hospital in a city located in the Southeastern Anatolia Region of Turkey, and who were hospitalized in the Internal Diseases, Endocrinology, Physical Therapy and Rehabilitation and Cardiology Services. collected using the method. A pilot study was not conducted before starting the study. Before the study, all patients were informed about the study and their verbal and written consents were obtained.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients included in the study;
- •18 years and over Using insulin injections for at least six months or longer
- •Meeting the American Diabetes Association (ADA, 2021) diagnostic criteria for Type 2 diabetes
- •No communication and mental problems
- •Insulin injection made by himself or his family The patients who agreed to participate in the study.
排除标准
- •Patients excluded from the study;
- •Self or family member health personnel Those with advanced retinopathy, nephropathy, neuropathy
- •Diagnosed with type 1 diabetes
- •Pregnant or breastfeeding women
- •Patients who participated in another clinical trial concurrently or within 1 month prior to the start of the trial.
结局指标
主要结局
Fırst follow - up survey
时间窗: Fırst test-fırst applıcatıon both groups at the begınnıng of the research
Pretest data was obtained using the introductory information form, IASOF, VAS, and ITES. Patients were requested to apply their daily dose of insulin to themselves and patients' application skills were recorded by the researchers into IASOF as the 1st observation.
次要结局
- Last test survey(2 weeks after the fırst watch)
研究者
Serap Parlar Kılıç
Professor Doctor
Inonu University